A plausible explanation of the differential protective effect of fasting against chemotherapy is the attenuation of the Ras/MAPK and PI3K/Akt pathways downstream of decreased IGF-1 in normal cells contrary to the oncogene-driven constitutive activation of these pathways in cancer cells [120]. This evidence concerns the gene AKT1 and cancer.